Mercy David C. Pratt Cancer Center /ID# 269350 — St Louis, Missouri

Mercy David C. Pratt Cancer Center /ID# 269350 is a clinical research site located in St Louis, Missouri, United States 63141.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Mercy David C. Pratt Cancer Center /ID# 269350 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mercy David C. Pratt Cancer Center /ID# 269350?

Mercy David C. Pratt Cancer Center /ID# 269350 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mercy David C. Pratt Cancer Center /ID# 269350 conducted?

Mercy David C. Pratt Cancer Center /ID# 269350 has 1 clinical trials on record, with 1 currently active. Their work covers Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive.

Is Mercy David C. Pratt Cancer Center /ID# 269350 accredited by Crixeo Health?

Mercy David C. Pratt Cancer Center /ID# 269350 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mercy David C. Pratt Cancer Center /ID# 269350?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.